How HB 2641 changes current law

Compared against the Missouri Revised Statutes as published AI-generated reading aid — verify against the official bill.

This bill amends 4 section(s) of the Missouri Revised Statutes: Section 195.010, RSMo; Section 195.800, RSMo; Section 195.819, RSMo; Section 195.900, RSMo.

• Section 195.010, RSMo

  (b) Illegalhemp shall be destroyed in the most effective manner possible, and such destruction shall be verified by the Missouri state highway patrol; → bold-face "Hemp", the same meaning given to the term in section 195.900; (21) , the same meaning given to the term in section 195.900

  amended

• Section 195.800, RSMo

  agency, including employees therein, shall disclose to the federal government, any federal government employee, or any unauthorized third party the statewide list or any individual information of persons who have applied for or obtained a qualifying patient identification card, a qualifying patient cultivation identification card, or a primary caregiver identification card, as those cards are described in Article XIV, Section 1 of the Constitution of Missouri relating to the right to access medical marijuana, unless required to do so pursuant to a subpoena or court order issued by a court of competent jurisdiction. 2. person who knowingly violates the provisions of this section shall be

  amended

• Section 195.819, RSMo

  Constitution of Missouri, shall not create or retain any record containing the consumer's identifying information; provided, that a facility may create or retain such records if the consumer affirmatively agrees to such, in writing, and if the facility does not refuse to provide services or sell goods to the consumer if he or she does not agree to the creation or retention of such records. The provisions of this section shall not apply to any record-keeping requirements relating to qualifying patients and primary caregivers under Article XIV, Section 1 of the Constitution of Missouri. Any dispensary facility that violates the provisions of this section shall be assessed a five-

  amended

• Section 195.900, RSMo

  Cannabinoid Control Act". 2.used in this section, the following terms mean: (1) "Department", the department of health and senior services; (2) "Division", the division of alcohol and tobacco control within the department of public safety; (3) "Hemp", the plant Cannabis sativa L. and any part of that plant, including the seeds thereof, and all derivatives, extracts, cannabinoids, isomers, acids, salts, and salts of isomers, whether growing or not, with a total tetrahydrocannabinol concentration, including tetrahydrocannabinolic acid, of not more than three-tenths of one percent on a dry-weight basis. "Hemp" shall include industrial hemp but shall not include the following: (Any viable seed from a Cannabis sativa L. plant that exceeds a total tetrahydrocannabinol concentration, including tetrahydrocannabinolic acid, of three- tenths of one percent on a dry-weight basis; (b) Any intermediate hemp-derived cannabinoid products containing: a. Cannabinoids that are not capable of being naturally produced by a Cannabis sativa L. plant; b.nabinoids that are capable of being naturally produced by a Cannabis sativa L. plant but that were synthesized or manufactured outside the plant; or c. More than three-tenths of one percent on a dry-weight basis of a combined total of tetrahydrocannabinols, including tetrahydrocannabinolic acid, and any other cannabinoids that have similar effects or are marketed as having similar effects on humans or animals as a tetrahydrocannabinol, as determined by the U.S. Secretary of Health and Human Services; (c)intermediate hemp-derived cannabinoid products marketed or sold as a final product or directly to an end consumer for personal or household use; or (d) Any final hemp-derived cannabinoid products containing: a. Cannabinoids that are not capable of being naturally produced by a Cannabis sativa L. plant; b. Cannabinoids that are capable of being naturally produced by a Cannabis sativa L. plant but that were synthesized or manufactured outside the plant; or c.ater than four-tenths of one milligram combined total per container of tetrahydrocannabinols, including tetrahydrocannabinolic acid, and any other cannabinoids that have similar effects or are marketed as having similar effects on humans or animals as a tetrahydrocannabinol, as determined by the U.S. Secretary of Health and Human Services; (4) "Hemp-derived cannabinoid product", any intermediate or final product derived from hemp, other than industrial hemp, that contains cannabinoids in any form and is intended for human or animal use through any means of application or administration including, but not limited to, inhalation, ingestion, or topical application. "Hemp-derived cannabinoid product" shall not include a drug that is the subject of an application approved under subsection (c) or (j) of Section 505 of the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. Section 355, as amended; (5) "Industrial hemp", hemp that is: (a) Grown for the use of the stalk of the plant, fiber produced from such a stalk, or any other noncannabinoid compound, derivative, mixture, preparation, or manufacture of such a stalk; (b) Grown for the use of the whole grain, oil, cake, nut, hull, or any other noncannabinoid compound, derivative, mixture, preparation, or manufacture of the seeds of such plant; (c) Grown for the purpose of producing microgreens or other edible hemp leaf products intended for human consumption that are derived from an immature hemp plant that is grown from seeds that do not exceed the threshold for total tetrahydrocannabinol concentration under paragraph (a) of subdivision (3) of this subsection; (d) A plant that does not enter the stream of commerce and is intended to support hemp research at an institution of higher education, as defined in Section 101 of the Higher Education Act of 1965, 20 U.S.C. Section 1001, as amended, or an independent research institute; or (e) Grown for the use of a viable seed of the plant produced solely for the prod

  amended